Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (840 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Corneal Opacities; Opacities, Corneal; Opacity, Corneal; Leukoma; Leukomas.
Where it fits in the MeSH classification
- Broader topics
- Corneal Diseases
- Narrower topics
- Arcus Senilis
Research landscape
PubMed indexes 4,429 records tagged with the MeSH heading “Corneal Opacity” (counts retrieved 2026-11-04). 404 of them (9.1%) were published from 2020 onward, and the busiest period so far is through 1999 with 2,541 records.
Reviews account for 267 records (6.0%) and meta-analyses for 5. Randomized controlled trials number 47 (1.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 2,541 |
| 2000-2009 | 678 |
| 2010-2019 | 806 |
| 2020 onward | 404 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 267 | 6.0% |
| Meta-analyses | 5 | 0.1% |
| Randomized controlled trials | 47 | 1.1% |
Method: PubMed query "Corneal Opacity"[MeSH Terms] with publication-type and date filters, retrieved 2026-11-04.
Reading the evidence in eye, ear, nose and throat
Eye, hearing, nose and throat studies rely on specialist tests (visual acuity, eye pressure, audiograms, scopes) and on patient-reported symptoms, which vary between people and with age. Some conditions improve without treatment, so comparison groups matter. Nothing on this page is advice about diagnosis or treatment; sudden loss of sight or hearing needs urgent care from a qualified clinician. Check how the outcome was tested, the age of the people studied and how long they were followed.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Ketamine/Xylazine-Induced Corneal Damage in Mice | 2015 | Research article Design not recorded in structured metadata | 42 | cc0 PMID 26222692 · DOI · PMC4519051 |
| FOXE3 contributes to Peters anomaly through transcriptional regulation of an autophagy-associated protein termed DNAJB1 | 2016 | Research article Design not recorded in structured metadata | 38 | cc by PMID 27218149 · DOI · PMC4820811 |
| Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts | 2016 | Research article Design not recorded in structured metadata | 26 | cc by PMID 27356868 · DOI · PMC4926301 |
| Artificial intelligence derived grading of mustard gas induced corneal injury and opacity | 2025 | Research article Design not recorded in structured metadata | 1 | cc by PMID 40594758 · DOI · PMC12216909 |
Ketamine/Xylazine-Induced Corneal Damage in Mice [1]
Abstract reading summary — source excerpts
- Opening excerpt
- PurposeWe have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity.
- Closing excerpt
- Use of yohimbine is suggested as a practical means of avoiding this complication.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (227 words)
PurposeWe have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity. The purpose of this study was to establish the clinical and histological features of this deleterious side effect, its sensitivity with respect to age and anesthesia protocol, and approaches for avoiding it.MethodsYoung C57BL/6J, C57BLKS/J, and SJL/J mice were treated with permutations of anesthesia protocols and compared using slit-lamp exams, optical coherence tomography, histologic analyses, and telemetric measurements of body temperature.ResultsKetamine/xylazine induces corneal damage in mice with a variable frequency. Among 12 experimental cohorts, corneal damage associated with ketamine/xylazine was observed in 9 of them. Despite various treatments to avoid corneal dehydration during anesthesia, the frequency of corneas experiencing damage among responding cohorts was 42% (26% inclusive of all cohorts), which is significantly greater than the natural prevalence (5%). The damage was consistent with band keratopathy. It appeared as a white or gray horizontal band located proximal to the pupil and was positive for subepithelial calcium deposition with von Kossa stain.ConclusionsThe sum of our clinical and histological observations is consistent with ketamine/xylazine-induced band keratopathy in mice. This finding is relevant for mouse studies involving the eye and/or vision-dependent behavioral assays, which would both be prone to artifact without appreciation of the damage caused by ketamine/xylazine anesthesia. Use of yohimbine is suggested as a practical means of avoiding this complication.
Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 26222692 · DOI · PMC4519051
FOXE3 contributes to Peters anomaly through transcriptional regulation of an autophagy-associated protein termed DNAJB1 [2]
Abstract reading summary — source excerpts
- Opening excerpt
- FOXE3 is a lens-specific transcription factor that has been associated with anterior segment ocular dysgenesis.
- Closing excerpt
- In conclusion, here we report DNAJB1 is a transcriptional target of FOXE3 in a novel pathway that is crucial for the development of the anterior segment of the eye.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (147 words)
FOXE3 is a lens-specific transcription factor that has been associated with anterior segment ocular dysgenesis. To determine the transcriptional target(s) of FOXE3 that are indispensable for the anterior segment development, we examined the transcriptome and the proteome of cells expressing truncated FOXE3 responsible for Peters anomaly identified through linkage-coupled next-generation whole-exome sequencing. We found that DNAJB1, an autophagy-associated protein, was the only candidate exhibiting differential expression in both screens. We confirmed the candidacy of DNAJB1 through chromatin immunoprecipitation and luciferase assays while knockdown of DNAJB1 in human lens epithelial cells resulted in a mitotic arrest. Subsequently, we targeted dnajb1a in zebrafish through injection of a splice-blocking morpholino. The dnajb1a morphants exhibited underdeveloped cataractous lenses with persistent apoptotic nuclei. In conclusion, here we report DNAJB1 is a transcriptional target of FOXE3 in a novel pathway that is crucial for the development of the anterior segment of the eye.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27218149 · DOI · PMC4820811
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts [3]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundAngiogenin (ANG), a component of tears, is involved in the innate immune system and is related with inflammatory disease.
- Closing excerpt
- This may support the targeting of immune-mediated corneal inflammation by using ANG.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (273 words)
BackgroundAngiogenin (ANG), a component of tears, is involved in the innate immune system and is related with inflammatory disease. We investigated whether ANG has an immune modulatory function in human corneal fibroblasts (HCFs).MethodsHCFs were cultured from excised corneal tissues. The gene or protein expression levels of interleukin (IL)-1beta (β), IL-4, IL-6, IL-8, IL-10, complements, toll-like receptor (TLR)4, myeloid differentiation primary response gene (MYD)88, TANK-binding kinase (TBK)1, IkappaB kinase-epsilon (IKK-ε) and nuclear factor-kappaB (NF-κB) were analyzed with or without ANG treatment in tumor necrosis factor-alpha (TNF-α)- or lipopolysaccharide (LPS)-induced inflammatory HCFs by real-time polymerase chain reaction (PCR), Western blotting and immunocytochemistry. Inflammatory cytokine profiles with or without ANG were evaluated through immunodot blot analysis in inflammatory HCFs. Corneal neovascularization and opacity in a rat model of corneal alkali burn were evaluated after application of ANG eye drops.ResultsANG decreased the mRNA levels of IL-1β, IL-6, IL-8, TNF-α receptor (TNFR)1, 2, TLR4, MYD88, and complement components except for C1r and C1s and elevated the mRNA expression of IL-4 and IL-10. Increased signal intensity of IL-6, IL-8 and monocyte chemotactic protein (MCP)-1 and MCP-2 induced by TNF-α or LPS was weakened by ANG treatment. ANG reduced the protein levels of IKK-ε by either TNF-α and LPS, and decreased TBK1 production induced by TNF-α, but not induced by LPS. The expression of NF-κB in the nuclei was decreased after ANG treatment. ANG application lowered corneal neovascularization and opacity in rats compared to controls.ConclusionThese results demonstrate that ANG reduces the inflammatory response induced by TNF-α or LPS in HCFs through common suppression of IKK-ε-mediated activation of NF-κB. This may support the targeting of immune-mediated corneal inflammation by using ANG.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 27356868 · DOI · PMC4926301
Artificial intelligence derived grading of mustard gas induced corneal injury and opacity [4]
Abstract reading summary — source excerpts
- Opening excerpt
- Artificial intelligence (AI) has emerged as a transformative tool in ophthalmology for disease diagnosis and prognosis.
- Closing excerpt
- This deep learning framework, combining Mask-RCNN with ResNet50 allows reliable and uniform grading of SM-induced corneal injury and opacity levels in affected eyes.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (193 words)
Artificial intelligence (AI) has emerged as a transformative tool in ophthalmology for disease diagnosis and prognosis. However, use of AI for assessing corneal damage due to chemical injury in live rabbits remains lacking. This study aimed to develop an AI-derived clinical classification model for an objective grading of corneal injury and opacity levels in live rabbits following ocular exposure of sulfur mustard (SM). An automated method to grade corneal injury minimizes diagnostic errors and enhances translational application of preclinical research in better human eyecare. SM induced corneal injury and opacity from 401 in-house rabbit corneal images captured with a clinical stereomicroscope were used. Three independent subject matter specialists classified corneal images into four health grades: healthy, mild, moderate, and severe. Mask-RCNN was employed for precise corneal segmentation and extraction, followed by classification using baseline convolutional neural network and transfer learning algorithms, including VGG16, ResNet101, DenseNet121, InceptionV3, and ResNet50. The ResNet50-based model demonstrated the best performance, achieving 87% training accuracy, and 85% and 83% prediction accuracies on two independent test sets. This deep learning framework, combining Mask-RCNN with ResNet50 allows reliable and uniform grading of SM-induced corneal injury and opacity levels in affected eyes.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40594758 · DOI · PMC12216909
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article The corneal fibrosis response to epithelial-stromal injury [5]
- Research article Corneal stromal wound healing: Major regulators and therapeutic targets [6]
- Research article Transparency, swelling and scarring in the corneal stroma [7]
- Research article Pediatric keratoplasty [8]
- Research article Trachoma [9]
- Research article Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis [10]
References
- Koehn D, Meyer KJ, Syed NA, Anderson MG. Ketamine/Xylazine-Induced Corneal Damage in Mice. . 2015. PMID 26222692 · DOI · PMC4519051
- Khan SY, Vasanth S, Kabir F, Gottsch JD, Khan AO, Chaerkady R, et al.. FOXE3 contributes to Peters anomaly through transcriptional regulation of an autophagy-associated protein termed DNAJB1. . 2016. PMID 27218149 · DOI · PMC4820811
- Lee SH, Kim KW, Joo K, Kim JC. Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts. . 2016. PMID 27356868 · DOI · PMC4926301
- Kumar R, Sinha DM, Sinha NR, Tripathi R, Hesemann N, Gupta S, et al.. Artificial intelligence derived grading of mustard gas induced corneal injury and opacity. . 2025. PMID 40594758 · DOI · PMC12216909
- Torricelli AA, Santhanam A, Wu J, Singh V, Wilson SE. The corneal fibrosis response to epithelial-stromal injury. Exp Eye Res. 2016. PMID 26675407 · DOI · PMC4683352
- Kamil S, Mohan RR. Corneal stromal wound healing: Major regulators and therapeutic targets. Ocul Surf. 2021. PMID 33127599 · DOI · PMC9183221
- Meek KM, Leonard DW, Connon CJ, Dennis S, Khan S. Transparency, swelling and scarring in the corneal stroma. Eye (Lond). 2003. PMID 14631399 · DOI
- Vanathi M, Panda A, Vengayil S, Chaudhuri Z, Dada T. Pediatric keratoplasty. Surv Ophthalmol. 2009. PMID 19298903 · DOI
- Wright HR, Turner A, Taylor HR. Trachoma. Lancet. 2008. PMID 18539226 · DOI
- Wang EY, Kong X, Wolle M, Gasquet N, Ssekasanvu J, Mariotti SP, et al.. Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis. Ophthalmology. 2023. PMID 36963570 · DOI · PMC10355344
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-11-04.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.